ArticleJMIRx med2024

Peer Review for "Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis".

AnonymousPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.